secwatch.observer — SEC 8-K summary
======================================

Issuer:     HCW Biologics Inc. (HCWB)
CIK:        0001828673
Form:       8-K
Filed at:   2025-05-23T23:59:59+00:00
Accession:  0000950170-25-076994
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

HCW Biologics issues 126,000 shares upon Armistice warrant exercise
-------------------------------------------------------------------

- Issued 126,000 common shares to Armistice Capital Master Fund on May 22, 2025 upon exercise of pre-funded warrants at $0.0001/share.
- Remaining pre-funded warrants held by Armistice cover 210,000 shares as of May 22, 2025.
- This is the second exercise tranche; 177,140 shares were issued on May 15, 2025 from the same warrants.
- Exercise generates negligible proceeds to the company due to $0.0001 per share exercise price.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828673/000095017025076994/0000950170-25-076994-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828673/000095017025076994/hcwb-20250521.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-076994

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer